December 17, 2015
Proceeds Will Allow Company to Continue Commercialization and Accelerate Adoption of BlueStar® Mobile Prescription Therapy for Adults Living With Type 2 Diabetes BALTIMORE (GLOBE NEWSWIRE) — Digital health technology leader … Continued
December 16, 2015
ALISO VIEJO, Calif., PRNewswire — ClarVista Medical, Inc.(www.clarvistamedical.com), an ophthalmic device company developing the HARMONI® Modular IOL system, announced today that The Ophthalmologist, a leading publication in the field of … Continued
December 15, 2015
Data show Optune plus standard of care temozolomide extended overall survival and progression-free survival of newly diagnosed glioblastoma patients compared to temozolomide alone EF-14 trial results supported recent FDA approval of … Continued
December 02, 2015
HELIER, Jersey–(BUSINESS WIRE)– Preliminary data from COMET, a phase 2 randomized trial sponsored by Novocure (NASDAQ: NVCR), show that the use of Tumor Treating Fields (TTFields) therapy is safe in … Continued